West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,300 | 52,900 | 40,600 | 37,800 | 54,500 |
| Receivables | 78,800 | 81,000 | 83,700 | 114,500 | 76,300 |
| Inventories | 57,900 | 55,500 | 52,200 | 47,600 | 45,900 |
| Income taxes - deferred | 6,100 | 6,000 | 6,000 | 6,100 | 5,200 |
| Other current assets | 12,800 | 13,100 | 12,300 | 10,700 | 11,500 |
| TOTAL | $218,900 | $208,500 | $194,800 | $216,700 | $193,400 |
| Non-Current Assets | |||||
| PPE Net | 269,800 | 261,400 | 259,700 | 251,100 | 232,900 |
| Investments And Advances | 23,800 | 22,900 | 22,900 | 22,200 | 20,200 |
| Intangibles | 47,700 | 47,500 | 48,200 | 40,900 | 47,400 |
| Other Non-Current Assets | 76,000 | 78,000 | 79,200 | 92,700 | 81,700 |
| TOTAL | $417,300 | $409,800 | $410,000 | $406,900 | $382,200 |
| Total Assets | $636,200 | $618,300 | $604,800 | $623,600 | $575,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 11,600 |
| Accounts payable and accrued liabilities | 26,200 | 24,500 | 26,600 | 28,600 | 25,100 |
| Accrued Expenses | 51,400 | 50,300 | 49,700 | 79,700 | 62,900 |
| Other current liabilities | 29,400 | 28,500 | 29,900 | N/A | N/A |
| TOTAL | $107,300 | $108,100 | $109,800 | $118,900 | $104,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 162,400 | 153,200 | 148,600 | 167,000 | 162,700 |
| aiOther Non-Current Liabilities | 40,200 | 39,300 | 38,200 | 35,300 | 33,700 |
| TOTAL | $248,000 | $237,900 | $231,900 | $247,100 | $245,800 |
| Total Liabilities | $355,300 | $346,000 | $341,700 | $366,000 | $350,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,223 | 60,983 | 59,298 | 58,961 | 58,242 |
| Common Shares | 8,600 | 4,300 | 4,300 | 4,300 | 4,300 |
| Retained earnings | 290,500 | 289,500 | 285,000 | 281,200 | 267,200 |
| Other shareholders' equity | 11,700 | 6,100 | 15,200 | 19,000 | 2,600 |
| TOTAL | $280,900 | $272,300 | $263,100 | $257,600 | $225,600 |
| Total Liabilities And Equity | $636,200 | $618,300 | $604,800 | $623,600 | $575,600 |